Safety and Efficacy of Cangrelor in Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis
ConclusionCangrelor has comparable outcomes to clopidogrel in patients with acute coronary syndromes and can be used as a reliable alternative in this population.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Bleeding | Blood Transusion | Cardiology | Cardiovascular | Clopidogrel | Heart | Heart Attack | Plavix | Statistics | Study | Thrombosis